ACT Venture Partners
Overview
ACT Venture Partners is a venture capital fund manager that invests in early-stage deep-tech and deep-tech enabler ventures. The firm backs technical founders with the vision and capability to transform industries, offering breakthrough technologies and novel business models. ACT focuses on AI, quantum technologies, sustainability, space, and health tech, targeting innovations that redefine industries and address global challenges. ACT primarily leads pre-seed and seed-stage investments and continues supporting startups through Series A and B, ensuring they have the resources to scale globally and drive lasting impact.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Qubitrium | Apr 2026 | Seed | Co-investor |
| Cellbricks Therapeutics | Mar 2026 | Seed | Co-investor |
| NxLite | Oct 2025 | Series A | Co-investor |
| Qubitrium | Sep 2024 | Seed | Lead |
| Meddenovo Drug Design | Jul 2024 | Pre Seed | Lead |
Key People
Okan KARA
Co-founder And Managing Partner
Erhan K.
Managing Partner
Gokhan Guner
Managing Partner
O. Gurcan Ozan
Partner
Tự Nguyễn
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.